Fazal Zaidi, MD, FAHA, FSVIN (@fazalzaidi9) 's Twitter Profile
Fazal Zaidi, MD, FAHA, FSVIN

@fazalzaidi9

Professor, Neurology, Director Interventional Neurology, Director Teleneurology, University of Toledo & ProMedica Toledo Hospital

ID: 1101483098120830978

calendar_today01-03-2019 14:03:29

77 Tweet

351 Followers

205 Following

Shashvat M. Desai (@shashvatdesai) 's Twitter Profile Photo

While the science of thrombectomy is now well established, path to global equity (device efficacy across ethnicities & affordability) is equally, if not more, challenging FIRST IN MAN use of Gravity Medical Technology Stentretriever is a small yet significant step towards 🌏parity

SVIN (@svinsociety) 's Twitter Profile Photo

May is #StrokeAwarenessMonth, & we ask you to join us in #SpreadingTheWord in all languages, to emphasize that time is brain ⏰🧠, & there is a cure for stroke 💉. Share your videos, donate to Mission Thrombectomy, & be sure to tag 5 friends. Every second (&video) counts!

Tudor G. Jovin, MD (@tudorgjovin) 's Twitter Profile Photo

Humbled to have co-led this trial showing benefit of MT in early presenting pts with unlimitedly large infarcts. Large core regardless of size = poor prognosis, but not treatment effect modifier. IMAGING CANNOT IDENTIFY PTS WHO DON'T BENEFIT FROM MT !! nejm.org/doi/full/10.10…

NeuroNews (@nn_publishing) 's Twitter Profile Photo

CLEVER trial results presented by Mouhammad Jumaa show that clevidipine is safe and effective in controlling blood pressure following a mechanical thrombectomy in ischaemic stroke patients #ESOC2024 European Stroke Org

CLEVER trial results presented by <a href="/Mouhammad_Jumaa/">Mouhammad Jumaa</a> show that clevidipine is safe and effective in controlling blood pressure following a mechanical thrombectomy in ischaemic stroke patients
#ESOC2024 <a href="/ESOstroke/">European Stroke Org</a>
Adnan Mujanović (@adnan_mujanovic) 's Twitter Profile Photo

💥Newest updates in large core💥Analysis of 60+ centers from the #CLEAR study shows benefit of EVT in real-world❗️ patients with large ischemic core (ASPECTS 0-5). Sincere thanks to all the collaborators on their great efforts! journals.sagepub.com/doi/10.1177/23…

💥Newest updates in large core💥Analysis of 60+ centers from the #CLEAR study shows benefit of EVT in real-world❗️ patients with large ischemic core (ASPECTS 0-5).  Sincere thanks to all the collaborators on their great efforts! 
journals.sagepub.com/doi/10.1177/23…
Galaxy Therapeutics (@galaxythera) 's Twitter Profile Photo

Galaxy Therapeutics has made it across the Pacific! We are honored to have our first case in Australasia region performed by Dr. James Caldwell at Auckland City Hospital. A great case with a great outcome. We look forward to treating many more patients in NZ/Australia. Osama Zaidat MD

Galaxy Therapeutics has made it across the Pacific!  We are honored to have our first case in Australasia region performed by Dr. James Caldwell at Auckland City Hospital. A great case with a great outcome. We look forward to treating many more patients in NZ/Australia.
<a href="/oozaidat/">Osama Zaidat MD</a>
David Altschul (@davidaltschulmd) 's Twitter Profile Photo

40s y/o remote hx of #hemorrhage as a teenager, he of seizures p/w headaches after exposure to fire in a kitchen. Angio showing what appears to be chronic venous congestion. A case of #venous #Moyamoya? Near total loss of deep venous drainage. #cerebrovascular #neurosurgery

SEAL IT ANEURYSM TRIAL (@sealtrial) 's Twitter Profile Photo

Exciting time for Galaxy Therapeutics.Inc; Galaxy Therapeutics as we start the journey of the IDE Pivotal clinical trial for the SEAL Intra-saccular aneurysm treatment device. If you want to be a site and be part of this journy, please email us at [email protected]

Alexandra Czap (@alexandraczap) 's Twitter Profile Photo

SLICE is coming to #SVIN24 Annual Meeting November 20-22nd, 2024 in San Diego, CA! For the first time, SVIN has partnered with SLICE - Worldwide / Next Frontiers / Workshops to bring attendees interactive workshops and LIVE plenary session featuring SLICE cases. REGISTER TODAY!!! svin.org/i4a/pages/inde…

Galaxy Therapeutics (@galaxythera) 's Twitter Profile Photo

Second patient enrolled by Dr.Asif Taqi and his team at Los Robles Regional Medical Center in California. Great results. We look forward to rapid enrollment as more sites come on line.

Second patient enrolled by Dr.Asif Taqi and his team at Los Robles Regional Medical Center in California.  Great results.  We look forward to rapid enrollment as more sites come on line.